ALECTOR, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.09 USD | 0.00% |
|
-9.75% | -36.22% |
Chart calendar Alector, Inc.
d9.4XtCi2lfwAEAU4_XIMHp80udGhTgN6zulDKeDVOBIGM.vh4h3w8J-FtLJe2_ZJSeiifKS3akBf6v0GOqRDz4DVaNOQXEIiiHOVFqzg~d2de3ce780b853a79942c8788a925a67
Upcoming events on Alector, Inc.
Past events on Alector, Inc.
| 2024-03-19 11:30 am | Stifel CNS Day |
| 2024-03-13 02:05 pm | Barclays Global Healthcare Conference |
| 2024-03-12 10:40 am | Leerink Partners Global Biopharma Conference |
| 2024-03-05 10:30 am | TD Cowen Health Care Conference - Panel |
| 2024-02-27 04:30 pm | Q4 2023 Earnings Call |
| 2024-02-27 04:05 pm | Q4 2023 Earnings Release |
| 2023-12-13 11:00 am | Investor Meeting |
| 2023-12-07 12:00 pm | Investor Meeting |
| 2023-11-14 11:30 am | Stifel Healthcare Conference |
| 2023-11-07 04:05 pm | Q3 2023 Earnings Release |
| 2023-09-28 08:35 am | Cantor Global Healthcare Conference |
| 2023-09-12 02:30 pm | H.C. Wainwright Global Investment Conference |
| 2023-09-11 04:55 pm | Morgan Stanley Global Healthcare Conference |
| 2023-08-03 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-03 04:05 pm | Q2 2023 Earnings Release |
| 2023-06-14 11:00 am | Annual General Meeting |
| 2023-06-13 01:40 pm | Goldman Sachs Global Healthcare Conference - Fireside Chat |
| 2023-05-10 05:20 pm | Bank of America Healthcare Conference |
| 2023-05-04 04:05 pm | Q1 2023 Earnings Release |
| 2023-03-28 12:00 pm | Stifel CNS Day |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 21,2 21,6 -1.89% | 21,1 24,1 -12.63% | 207 244 -15.04% | 134 149 -10.42% | 97,1 91,1 6.53% | 62,3 |
|
EBITDA Million USD | Released Forecast Spread | -111 -108 -2.19% | -189 -183 -3.57% | -31,0 -74,6 58.43% | -132 -110 -19.65% | -146 -161 9.26% | -200 |
|
EBIT Million USD | Released Forecast Spread | -114 -112 -1.94% | -195 -192 -1.77% | -37,4 30,1 -223.94% | -138 -120 -14.98% | -152 -172 11.81% | -227 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -105 -105 0.09% | -190 -189 -0.59% | -36,3 25,6 -241.81% | -130 -114 -13.75% | -125 -152 17.62% | -200 |
|
Net income Million USD | Released Forecast Spread | -105 -106 0.7% | -190 -190 -0.1% | -36,3 43,3 -183.82% | -133 -119 -11.79% | -130 -154 15.49% | -201 |
|
EPS USD | Released Forecast Spread | -1,71 -1,67 -2.55% | -2,45 -2,42 -1.16% | -0,45 0,52 -186.54% | -1,62 -1,45 -11.94% | -1,56 -1,83 14.74% | -2,14 |
| Announcement Date | 24/03/20 | 25/02/21 | 24/02/22 | 28/02/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 14,0 83,8 -83.31% | 24,5 78,7 -68.9% | 79,9 30,0 165.8% | 14,9 31,4 -52.68% | 14,4 25,9 -44.21% | 16,5 6,92 139.32% | 56,2 4,18 1243.76% | 9,11 9,97 -8.62% | 15,2 8,84 71.89% | 15,8 | 15,8 | 15,8 | 15,8 | 250 |
|
EBITDA Million USD | Released Forecast Spread | -46,0 -67,3 31.63% | |||||||||||||
|
EBIT Million USD | Released Forecast Spread | -55,7 22,9 -343.55% | -44,1 8,43 -623.13% | 9,48 -40,4 123.47% | -47,7 -41,0 -16.5% | -55,4 -45,0 -23.07% | -50,1 -64,8 22.67% | -3,59 -68,3 94.74% | -50,6 -59,0 14.21% | -47,5 -70,9 33.05% | -52,1 | -55,0 | -57,9 | -56,8 | 191 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -55,6 6,35 -975.52% | -43,9 46,2 -195.04% | 10,9 -39,2 127.85% | -45,4 -55,3 17.93% | -51,7 -43,8 -18.07% | -45,0 -57,1 21.26% | 2,77 -64,4 104.3% | -43,2 -54,9 21.21% | -39,8 -66,5 40.24% | -47,2 | -50,4 | -53,5 | -48,9 | 197 |
|
Net income Million USD | Released Forecast Spread | -55,6 6,35 -975.52% | -44,6 70,2 -163.52% | 9,88 -39,3 125.16% | -46,1 -46,0 -0.28% | -52,4 -44,7 -17.37% | -45,9 -58,3 21.33% | 1,38 -66,2 102.08% | -44,5 -54,7 18.76% | -41,4 -66,7 37.86% | -50,1 | -53,5 | -51,8 | -49,2 | 188 |
|
EPS USD | Released Forecast Spread | -0,68 0,07 -1130.3% | -0,54 0,68 -179.41% | 0,12 -0,48 125.23% | -0,56 -0,56 -0.6% | -0,63 -0,54 -16.67% | -0,55 -0,73 24.66% | 0,02 -0,80 102.51% | -0,53 -0,67 21.04% | -0,49 -0,77 36.63% | -0,54 | -0,55 | -0,54 | -0,51 | 1,93 |
| Announcement Date | 24/02/22 | 05/05/22 | 04/08/22 | 08/11/22 | 28/02/23 | 04/05/23 | 03/08/23 | 07/11/23 | 27/02/24 | - | - | - | - | - |
More events
Past sector events for Alector, Inc.
| 2024-04-17 | BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-17 | JIANGSU YAHONG MEDITECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-12 | SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release |
| 2024-04-10 07:00 am | NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-04-08 | MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-02 03:06 am | TAIMED BIOLOGICS INC.: March 2024 Sales and Revenue Release |
| 2024-03-31 | PEPTRON, INC.: Q4 2023 Earnings Release (Projected) |
| 2024-03-31 | BIONEER CORPORATION: Q4 2023 Earnings Release (Projected) |
| 2024-03-29 08:30 am | INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release |
| 2024-03-28 | BIO-THERA SOLUTIONS, LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALEC Stock
- Calendar Alector, Inc.
